Sudden death of a patient in complete remission after anthracycline therapy for acute lymphoblastic leukemia

Pediatrics International

Volumn 42, Issue 3, 2000, Pages 319-321

  Tsuda, Naoya ^a   Oka, Ryuji ^a   Kajino, Hiroki ^a   Kajino, Mayumi ^a   Okuno, Akimasa ^a  

^a ASAHIKAWA MEDICAL COLLEGE   (Japan)

Author keywords

Anthracycline; QTc dispersion; Sudden death

Indexed keywords

ANTHRACYCLINE DERIVATIVE; ASPARAGINASE; DOXORUBICIN; PIRARUBICIN; PREDNISOLONE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; CANCER REGRESSION; CASE REPORT; CHILD; DISEASE COURSE; FEMALE; HUMAN; PRIORITY JOURNAL; SUDDEN DEATH; TREATMENT OUTCOME;

ANTIBIOTICS, ANTINEOPLASTIC; CHILD, PRESCHOOL; DEATH, SUDDEN, CARDIAC; DOXORUBICIN; ELECTROCARDIOGRAPHY; FATAL OUTCOME; FEMALE; HUMANS; LEUKEMIA, LYMPHOCYTIC, ACUTE; REMISSION INDUCTION;

EID: 0034048029     PISSN: 13288067     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1442-200X.2000.01212.x     Document Type: Article

References (10)

1. 1 Kantrowitz NE, Bristow MR. Cardiotoxicity of antitumor agents. Prog. Cardiovasc. Dis. 1984; 27: 195-9.
2. 2 Leandro J, Dyck J, Poppe D et al. Cardiac dysfunction late after cardiotoxic therapy for childhood cancer. Am. J. Cardiol. 1994; 74: 1152-6.
3. 3 Bender KS, Shematek JP, Leventhal BG, Kan JS. QT interval prolongation associated with anthracycline cardiotoxicity. J. Pediatr. 1984; 105: 442-4.
4. 4 Gilladoga AC, Manuel C, Tan CTC, Wollner N, Sternberg SS, Murphy ML. The cardiotoxicity of adriamycin and daunomycin in children. Cancer. 1976; 37 (Suppl.): 1070-8.
5. 5 Lefrak EA, Pitha J, Rosenheim S, Gottlieb JA. A clinicopathologic analysis of adriamycin cardiotoxicity. Cancer 1973; 32: 302-14.
6. 6 Lenaz L, Page JA. Cardiotoxicity of adriamycin and related anthracyclines. Cancer Treat. Rev. 1976; 3: 111-20.
7. 7 Fulkerson PK, Talley R, Kleinman D et al. Noninvasive profile in the prospective monitoring of adriamycin cardiomyopathy. Cancer Treat. Rep. 1978; 62: 881-6.
8. 8 Steinherz L, Steinherz P. Delayed cardiac toxicity from anthracycline therapy. Pediatrician 1991; 18: 49-52.
9. 9 Hii JT, Wyse DG, Gillis AM, Duff HJ, Solylo MA, Mitchell LB. Precardial QT interval dispersion as a marker of torsades pointes. Disparate effects of class Ia antiarrhythmic drugs and amiodarone. Circulation 1992; 86: 1376-82.
10. 10 Pye M, Quinn AC, Cobbe SM. QT interval dispersion: A non-invasive marker of susceptibility to arrhythmia in patients with sustained ventricular arrhythmias. Br. Heart J. 1994; 71: 511-14.